Monopar Therapeutics Inc. (MNPR) closed the last trading session at $34.51, gaining 2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $52.20 indicates a 51.3% upside potential.The average comprises five short-term price targets ranging from a low of $37 to a high of $76, with a standard deviation of $15.69. While the lowest estimate indicates an increase of 7.2% from the current p ...

Shares of Copa Holdings (CPA) have gained 5.4% over the past four weeks to close the last trading session at $107.42, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $152.73 indicates a potential upside of 42.2%.The mean estimate comprises 11 short-term price targets with a standard deviation of $19.78. While the lowest estimate of $125 indicates a 16.4% increase from the curren ...

West Pharmaceutical Services (WST) closed the last trading session at $223.77, gaining 2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $284 indicates a 26.9% upside potential.The average comprises 10 short-term price targets ranging from a low of $245 to a high of $355, with a standard deviation of $34.94. While the lowest estimate indicates an increase of 9.5% from the current ...

Shares of BILL Holdings (BILL) have gained 2% over the past four weeks to close the last trading session at $45.62, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $66.75 indicates a potential upside of 46.3%.The average comprises 24 short-term price targets ranging from a low of $40 to a high of $120, with a standard deviation of $20.19. While the lowest estimate indicates a de ...

6 June 2025 | 8:12PM HKT China Basic Materials China commodities: Refreshing earnings estimates Trina Chen +852-2978-2678 | trina.chen@gs.com Goldman Sachs (Asia) L.L.C. Joy Zhang +852-2978-6545 | joy.x.zhang@gs.com Goldman Sachs (Asia) L.L.C. Roy Shi +852-2978-0110 | roy.shi@gs.com Goldman Sachs (Asia) L.L.C. Fiona Ye +852-2978-0680 | fiona.ye@gs.com Goldman Sachs (Asia) L.L.C. Daisy Dai +852-2978-7904 | daisy.dai@gs.com Goldman Sachs (Asia) L.L.C. We refresh our earnings estimates for our China commoditie ...

Shares of EverQuote (EVER) have gained 6.4% over the past four weeks to close the last trading session at $24.61, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $34.17 indicates a potential upside of 38.9%.The mean estimate comprises six short-term price targets with a standard deviation of $2.79. While the lowest estimate of $30 indicates a 21.9% increase from the current pric ...

Natural Gas Services (NGS) closed the last trading session at $24.51, gaining 27.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $36.25 indicates a 47.9% upside potential.The mean estimate comprises four short-term price targets with a standard deviation of $5.97. While the lowest estimate of $32 indicates a 30.6% increase from the current price level, the most optimistic analys ...

Verve Therapeutics (VERV) closed the last trading session at $5.29, gaining 25.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $24.75 indicates a 367.9% upside potential.The average comprises eight short-term price targets ranging from a low of $15 to a high of $39, with a standard deviation of $7.81. While the lowest estimate indicates an increase of 183.6% from the current pri ...

Green Dot (GDOT) closed the last trading session at $9.45, gaining 10.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $12.25 indicates a 29.6% upside potential.The mean estimate comprises four short-term price targets with a standard deviation of $2.06. While the lowest estimate of $10 indicates a 5.8% increase from the current price level, the most optimistic analyst expects th ...

Amneal Pharmaceuticals (AMRX) closed the last trading session at $7.45, gaining 3.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $11.50 indicates a 54.4% upside potential.The mean estimate comprises four short-term price targets with a standard deviation of $0.58. While the lowest estimate of $11 indicates a 47.7% increase from the current price level, the most optimistic analy ...